New weight management drug enters first human testing
NCT ID NCT06493084
Summary
This early-stage study aims to test the safety and how the body processes a new injection called LAE102. It will involve 160 healthy and overweight volunteers to see how well they tolerate different doses. The research will also gather initial information on whether the injection affects biological markers related to weight.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESE VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan Zhongshan Hospital
RECRUITINGShanghai, Shanghai Municipality, 201203, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.